Metabolomics of cocaine: Implications in toxicity

Toxicology Mechanisms and Methods

Volumn 25, Issue 6, 2015, Pages 494-500

  Dinis Oliveira, Ricardo Jorge ^a,b,c  

^a INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

"crack"; Anhydroecgonine methyl ester; cocaethylene; cocaine; metabolism; norcocaine

Indexed keywords

ANHYDROECGONINE METHYL ESTER; BENZOYLECGONINE; COCAINE; COCAINE DERIVATIVE; ECGONINE METHYL ESTER; HOMOCOCAINE; NORCOCAINE; PYROLYTIC PRODUCT; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT;

AEROBIC METABOLISM; ANAEROBIC METABOLISM; BLOOD BRAIN BARRIER; COCAINE DEPENDENCE; DRUG DETOXIFICATION; HUMAN; HYDROLYSIS; HYDROXYLATION; METABOLOMICS; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; PYROLYSIS; REVIEW; TRANSESTERIFICATION; ANIMAL; BIOTRANSFORMATION; CHEMICAL STRUCTURE; PROCEDURES; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

ANIMALS; BIOTRANSFORMATION; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; HUMANS; METABOLOMICS; MOLECULAR STRUCTURE; RISK ASSESSMENT; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICITY TESTS;

EID: 84942501328     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2015.1072612     Document Type: Review

References (80)

1. Ambre J, Ruo TI, Nelson J, Belknap S. (1988). Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans. J Anal Toxicol 12: 301-6
2. Aoki K, Ohmori M, Takimoto M, et al. (1997). Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur J Pharmacol 336: 43-9
3. Apantaku-Olajide T, Darker CD, Smyth BP. (2013). Onset of cocaine use: associated alcohol intoxication and psychosocial characteristics among adolescents in substance abuse treatment. J Addict Med 7: 183-8
4. Askalsky P, Kalapatapu RK, Foltin RW, Comer SD. (2015). Butyrylcholinesterase levels and subjective effects of smoked cocaine in healthy cocaine users. Am J Drug Alcohol Abuse 41: 161-5
5. Bailey DN. (1999). Quinidine inhibition of cocaethylene degradation in human serum in vitro: a preliminary study. Ther Drug Monit 21:301-3
6. Baselt RC. (2014). Disposition of drugs and toxic chemicals in man. Seal Beach (CA): Biomedical Publications
7. Boelsterli UA, Goldlin C. (1991). Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch Toxicol 65: 351-60
8. Boelsterli UA, Wolf A, Goldlin C. (1993). Oxygen free radical production mediated by cocaine and its ethanol-derived metabolite, cocaethylene, in rat hepatocytes. Hepatology 18: 1154-61
9. Brzezinski MR, Spink BJ, Dean RA, et al. (1997). Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. Drug Metab Dispos 25: 1089-96
10. Cami J, Farre M, Gonzalez ML, et al. (1998). Cocaine metabolism in humans after use of alcohol. Clinical and research implications. Recent Dev Alcohol 14: 437-55
11. Cone EJ. (1995). Pharmacokinetics and pharmacodynamics of cocaine. J Anal Toxicol 19: 459-78
12. Cone EJ. (1998). Recent discoveries in pharmacokinetics of drugs of abuse. Toxicol Lett 102-103: 97-101
13. Cone EJ, Tsadik A, Oyler J, Darwin WD. (1998). Cocaine metabolism and urinary excretion after different routes of administration. Ther Drug Monit 20: 556-60
14. Dean RA, Bosron WF, Zachman FM, et al. (1997). Effects of ethanol on cocaine metabolism and disposition in the rat. NIDA Res Monogr 173: 35-47
15. Dean RA, Christian CD, Sample RH, Bosron WF. (1991). Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine. FASEB J 5: 2735-9
16. Devi BG, Chan AW. (1997). Impairment of mitochondrial respiration and electron transport chain enzymes during cocaine-induced hepatic injury. Life Sci 60: 849-55
17. Dinis-Oliveira RJ. (2014). Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity. Bioanalysis 6: 3155-9
18. Dinis-Oliveira RJ, Carvalho F, Duarte JA, et al. (2012). Clinical and forensic signs related to cocaine abuse. Curr Drug Abuse Rev 5: 64-83
19. Dinis-Oliveira RJ, Carvalho F, Duarte JA, et al. (2010). Collection of biological samples in forensic toxicology. Toxicol Mech Methods 20: 363-414
20. Edwards DJ, Bowles SK. (1988). Protein binding of cocaine in human serum. Pharm Res 5: 440-2
21. Erzouki HK, Allen AC, Newman AH, et al. (1995). Effects of cocaine, cocaine metabolites and cocaine pyrolysis products on the hindbrain cardiac and respiratory centers of the rabbit. Life Sci 57: 1861-8
22. Evans SM, Cone EJ, Henningfield JE. (1996). Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther 279: 1345-56
23. Fandiño AS, Karas M, Toennes SW, Kauert G. (2002). Identification of anhydroecgonine methyl ester N-oxide, a new metabolite of anhydroecgonine methyl ester, using electrospray mass spectrometry. J Mass Spectrom 37: 525-32
24. Fandino AS, Toennes SW, Kauert GF. (2002). Studies on hydrolytic and oxidative metabolic pathways of anhydroecgonine methyl ester (methylecgonidine) using microsomal preparations from rat organs. Chem Res Toxicol 15: 1543-8
25. Farré M, De La Torre R, González ML, et al. (1997). Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther 283: 164-76
26. Foltin RW, Fischman MW, Pippen PA, Kelly TH. (1993). Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans. Drug Alcohol Depend 32: 93-106
27. Goldstein RA, DesLauriers C, Burda A, Johnson-Arbor K. (2009a). Cocaine: history, social implications, and toxicity: a review. Semin Diagn Pathol 26: 10-17
28. Goldstein RA, DesLauriers C, Burda AM. (2009b). Cocaine: history, social implications, and toxicity-A review. Dis Mon 55: 6-38
29. Graziani M, Nencini P, Nistico R. (2014). Genders and the concurrent use of cocaine and alcohol: pharmacological aspects. Pharmacol Res 87: 60-70
30. Harris DS, Everhart ET, Mendelson J, Jones RT. (2003). The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend 72: 169-82
31. Hasin DS, Stinson FS, Ogburn E, Grant BF. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64: 830-42
32. Hatfield MJ, Tsurkan L, Hyatt JL, et al. (2010). Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin. Br J Pharmacol 160: 1916-28
33. Hawks RL, Kopin IJ, Colburn RW, Thoa NB. (1974). Norcocaine: a pharmacologically active metabolite of cocaine found in brain. Life Sci 15: 2189-95
34. Herbst ED, Harris DS, Everhart ET, et al. (2011). Cocaethylene formation following ethanol and cocaine administration by different routes. Exp Clin Psychopharmacol 19: 95-104
35. Higgins ST, Budney AJ, Bickel WK, et al. (1994). Alcohol dependence and simultaneous cocaine and alcohol use in cocaine-dependent patients. J Addict Dis 13: 177-89
36. Higgins ST, Rush CR, Hughes JR, et al. (1992). Effects of cocaine and alcohol, alone and in combination, on human learning and performance. J Exp Anal Behav 58: 87-105
37. Isenschmid DS, Fischman MW, Foltin RW, Caplan YH. (1992). Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine. J Anal Toxicol 16: 311-14
38. Isenschmid DS, Levine BS, Caplan YH. (1989). A comprehensive study of the stability of cocaine and its metabolites. J Anal Toxicol 13: 250-6
39. Jacob 3rd P, Jones RT, Benowitz NL, et al. (1990). Cocaine smokers excrete a pyrolysis product, anhydroecgonine methyl ester. J Toxicol Clin Toxicol 28: 121-5
40. Jatlow P. (1988). Cocaine: analysis, pharmacokinetics, and metabolic disposition. Yale J Biol Med 61: 105-13
41. Jatlow P, Barash PG, Van Dyke C, et al. (1979). Cocaine and succinylcholine sensitivity: a new caution. Anesth Analg 58: 235-8
42. Jeffcoat AR, Perez-Reyes M, Hill JM, et al. (1989). Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos 17: 153-9
43. Jufer RA, Walsh SL, Cone EJ. (1998). Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use. J Anal Toxicol 22: 435-44
44. Jufer RA, Wstadik A, Walsh SL, et al. (2000). Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J Anal Toxicol 24: 467-77
45. Karch SB. (2009). Karch's pathology of drug abuse. Boca Raton (FL), London: CRC Press
46. Kloss MW, Rosen GM, Rauckman EJ. (1983). N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Mol Pharmacol 23: 482-5
47. Kolbrich EA, Barnes AJ, Gorelick DA, et al. (2006). Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol 30: 501-10
48. Kovacic P. (2005). Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. Med Hypotheses 64: 350-6
49. Laizure SC, Mandrell T, Gades NM, Parker RB. (2003). Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. Drug Metab Dispos 31: 16-20
50. Langman LJ, Bjergum MW, Williamson CL, Crow FW. (2009). Sensitive method for detection of cocaine and associated analytes by liquid chromatography-Tandem mass spectrometry in urine. J Anal Toxicol 33: 447-55
51. Lockridge O. (2015). Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther 148: 34-46
52. Logan BK, Peterson KL. (1994). The origin and significance of ecgonine methyl ester in blood samples. J Anal Toxicol 18: 124-5
53. Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT. (2000). Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (Ecstasy'). Toxicol Lett 112-113: 133-42
54. McCance EF, Price LH, Kosten TR, Jatlow PI. (1995). Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther 274: 215-23
55. Meeker JE, Reynolds PC. (1990). Fetal and newborn death associated with maternal cocaine use. J Anal Toxicol 14: 379-82
56. Misra AL, Nayak PK, Bloch R, Mule SJ. (1975). Estimation and disposition of [3H]benzoylecgonine and pharmacological activity of some cocaine metabolites. J Pharm Pharmacol 27: 784-6
57. Moolchan ET, Cone EJ, Wstadik A, et al. (2000). Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis. J Anal Toxicol 24: 458-66
58. Nakahara Y, Ishigami A. (1991). Inhalation efficiency of free-base cocaine by pyrolysis of crack' and cocaine hydrochloride. J Anal Toxicol 15: 105-9
59. Ndikum-Moffor FM, Schoeb TR, Roberts SM. (1998). Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine. J Pharmacol Exp Ther 284: 413-19
60. Nelson LS, Hoffman RS, Lewin NA, et al. (2011). Goldfranks toxicologic emergencies. London: McGraw-Hill Professional
61. Paul BD, McWhorter LK, Smith ML. (1999). Electron ionization mass fragmentometric detection of urinary ecgonidine, a hydrolytic product of methylecgonidine, as an indicator of smoking cocaine. J Mass Spectrom 34: 651-60
62. Pellinen P, Kulmala L, Konttila J, et al. (2000). Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes. Arch Toxicol 74: 511-20
63. Porter WH. (2006). Clinical toxicology. In Burtis CA, Ashwood ER, Bruns DE., eds. Tietz textbook of clinical chemistry and molecular diagnostics, St. Louis (MO): Elsevier Saunders, 1287-390
64. Roberts SM, Harbison RD, James RC. (1993). Inhibition by ethanol of the metabolism of cocaine to benzoylecgonine and ecgonine methyl ester in mouse and human liver. Drug Metab Dispos 21: 537-41
65. Rubio G, Manzanares J, Jiménez M, et al. (2008). Use of cocaine by heavy drinkers increases vulnerability to developing alcohol dependence: a 4-year follow-up study. J Clin Psychiatry 69: 563-70
66. Salloum IM, Daley DC, Cornelius JR, et al. (1996). Disproportionate lethality in psychiatric patients with concurrent alcohol and cocaine abuse. Am J Psychiatry 153: 953-5
67. Satoh T, Taylor P, Bosron WF, et al. (2002). Current progress on esterases: from molecular structure to function. Drug Metabol Dispos 30: 488-93
68. Scheidweiler KB, Plessinger MA, Shojaie J, et al. (2003). Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine pyrolyzate. J Pharmacol Exp Ther 307: 1179-87
69. Schwer H, Langmann T, Daig R, et al. (1997). Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem Biophys Res Commun 233: 117-20
70. Shanti CM, Lucas CE. (2003). Cocaine and the critical care challenge. Crit Care Med 31: 1851-9
71. Shimomura ET, Hodge GD, Paul BD. (2001). Examination of postmortem fluids and tissues for the presence of methylecgonidine, ecgonidine, cocaine, and benzoylecgonine using solid-phase extraction and gas chromatography-mass spectrometry. Clin Chem 47: 1040-7
72. Stewart DJ, Inaba T, Lucassen M, Kalow W. (1979). Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther 25: 464-8
73. Stewart DJ, Inaba T, Tang BK, Kalow W. (1977). Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci 20: 1557-63
74. Stinson FS, Grant BF, Dawson DA, et al. (2005). Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Drug Alcohol Depend 80: 105-16
75. Verstraete AG. (2004). Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26: 200-5
76. Wang PP, Bartlett MG. (1999). Identification and quantification of cocaine N-oxide: a thermally labile metabolite of cocaine. J Anal Toxicol 23: 62-6
77. Warner A, Norman AB. (2000). Mechanisms of cocaine hydrolysis and metabolism in vitro and in vivo: a clarification. Ther Drug Monit 22: 266-70
78. Warner EA. (1993). Cocaine abuse. Ann Intern Med 119: 226-35
79. Wood RW, Shojaie J, Fang CP, Graefe JF. (1996). Methylecgonidine coats the crack particle. Pharmacol Biochem Behav 53: 57-66
80. Yang Y, Ke Q, Cai J, et al. (2001). Evidence for cocaine and methylecgonidine stimulation of M(2) muscarinic receptors in cultured human embryonic lung cells. Br J Pharmacol 132: 451-60